Does Severity of Donor Acute Kidney Injury Influence Outcomes Following Kidney Transplantation?
Clinical Transplantation · 2024-08 · 38 (8)
DOI: 10.1111/ctr.15425 ↗At a glance
Journal article in Clinical Transplantation, published online on 2024-08-08. Written by Alexandra R Monetti and 11 co-authors. Institution: Department of Surgery, Wake Forest University School of Medicine, Winston-Salem, USA. Major MEDLINE topics: Acute Kidney Injury, Kidney Transplantation, Tissue Donors, Graft Survival. Cited 2 times so far (Crossref); 50 references.
Abstract (original language)
Introduction
The study purpose was to review retrospectively our single‐center experience transplanting kidneys from deceased donors (DD) with acute kidney injury (AKI) according to terminal serum creatinine (tSCr) level.
Methods
AKI kidneys were defined by a doubling of the DD's admission SCr and a tSCr ≥ 2.0 mg/dL.
Results
From 1/07 to 11/21, we transplanted 236 AKI DD kidneys, including 100 with a tSCr ≥ 3.0 mg/dL (high SCr AKI group, mean tSCr 4.2 mg/dL), and the remaining 136 from DDs with a tSCr of 2.0–2.99 mg/dL (lower SCr AKI group, mean tSCr 2.4 mg/dL). These two AKI groups were compared to 996 concurrent control patients receiving DD kidneys with a tSCr < 1.0 mg/dL. Mean follow‐up was 69 months. Delayed graft function (DGF) rates were 51% versus 46% versus 29% ( p < 0.0001), and 5‐year patient and death‐censored kidney graft survival rates were 96.8% versus 83.5% versus 82.2% ( p = 0.002) and 86.7% versus 77.8% versus 78.8% ( p = 0.18) in the high tSCr AKI versus lower tSCr AKI versus control groups, respectively.
Conclusions
Despite a higher incidence of DGF, patients receiving kidneys from DDs with tSCr levels ≥3.0 mg/dL have acceptable medium‐term outcomes compared to either AKI DDs with a lower tSCr or DDs with a tSCr < 1.0 mg/dL.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Surgery, Wake Forest University School of Medicine, Winston-Salem, USA.
- Department of Surgery, Section of Transplantation, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
- Department of Medicine, Section of Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
ORCID profiles: Alexandra R Monetti, Colleen L Jay, Berjesh Sharda, Giuseppe Orlando, Robert J Stratta
Cite
APA
Monetti, A. R., Webb, C. J., Jay, C. L., McCracken, E., Sharda, B., Garner, M., Farney, A. C., Orlando, G., Reeves-Daniel, A., Mena-Gutierrez, A., Sakhovskaya, N., & Stratta, R. J. (2024). Does Severity of Donor Acute Kidney Injury Influence Outcomes Following Kidney Transplantation?. Clinical Transplantation, 38(8). https://doi.org/10.1111/ctr.15425
Vancouver
Monetti AR, Webb CJ, Jay CL, McCracken E, Sharda B, Garner M, et al. Does Severity of Donor Acute Kidney Injury Influence Outcomes Following Kidney Transplantation?. Clinical Transplantation. 2024;38(8). doi:10.1111/ctr.15425
BibTeX
@article{Monetti2024,
author = {Monetti, Alexandra R and Webb, Christopher J and Jay, Colleen L and McCracken, Emily and Sharda, Berjesh and Garner, Matthew and Farney, Alan C and Orlando, Giuseppe and Reeves-Daniel, Amber and Mena-Gutierrez, Alejandra and Sakhovskaya, Natalia and Stratta, Robert J},
title = {Does Severity of Donor Acute Kidney Injury Influence Outcomes Following Kidney Transplantation?},
journal = {Clinical Transplantation},
year = {2024},
volume = {38},
number = {8},
doi = {10.1111/ctr.15425}
}
EUVIMED